Literature DB >> 21158710

Searching for novel cancer chemopreventive plants and their products: the genus Zanthoxylum.

Francesco Epifano1, Massimo Curini, Maria Carla Marcotullio, Salvatore Genovese.   

Abstract

The genus Zanthoxylum (Rutaceae) comprises about 250 species, of which many are used as food, often as condiments, substituting pepper due to the pungent taste of fruits, seeds, leaves, and bark, and therapeutic remedies especially in Eastern Asian countries and in Central America. The whole plant is also consumed as an ingredient of soups and salads. The aim of this review is to examine in detail from a phytochemical and pharmacological point of view what is reported in the current literature about the anti-cancer and chemopreventive properties of phytopreparations or individual active compounds obtained from edible plants belonging to this genus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21158710     DOI: 10.2174/138945011798184128

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  4 in total

1.  Isolation of endophytic fungi with antimicrobial activity from medicinal plant Zanthoxylum simulans Hance.

Authors:  Jimmy Kuo; Chin-Feng Chang; Wei-Chiung Chi
Journal:  Folia Microbiol (Praha)       Date:  2021-02-05       Impact factor: 2.099

2.  Effects of Frying Conditions on Volatile Composition and Odor Characteristics of Fried Pepper (Zanthoxylum bungeanum Maxim.) Oil.

Authors:  Ruijia Liu; Nan Qi; Jie Sun; Haitao Chen; Ning Zhang; Baoguo Sun
Journal:  Foods       Date:  2022-06-06

Review 3.  Zanthoxylum Species: A Comprehensive Review of Traditional Uses, Phytochemistry, Pharmacological and Nutraceutical Applications.

Authors:  Innocent Uzochukwu Okagu; Joseph Chinedu Ndefo; Emmanuel Chigozie Aham; Chibuike C Udenigwe
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

4.  Zanthoxylum zanthoxyloides Alkaloidal Extract Improves CCl4-Induced Hepatocellular Carcinoma-Like Phenotypes in Rats.

Authors:  Desmond Omane Acheampong; Isaac Kyei Baffour; Victor Yao Atsu Barku; Justice Kwaku Addo; Mainprice Akuoko Essuman; Alex Boye
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-21       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.